Reproterol-d3
Reproterol-d3 is the deuterium labeled Reproterol (HY-135490) . Reproterol is a dual acting β2-adrenoceptor agonist and PDE inhibitor. The theophylline constituent of Reproterol inhibits phosphodiesterase activity induced by adenylyl cyclase. Reproterol has the potential for asthma research[1][2].
Product Specifications
UNSPSC
12352005
Target
Adrenergic Receptor; Isotope-Labeled Compounds; Phosphodiesterase (PDE)
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling; Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C1N(C(N(C2=C1N(C=N2)CCCNC([2H])(C([2H])(C3=C(C(O)=C(C(O)=C3[H][2H])[H][2H])[H][2H])O)[2H])C)=O)C
Molecular Formula
C18H20D6N5O5
Molecular Weight
398.47
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human UBXN4 shRNA (UAS) - Lentiviral human UBXN4 shRNA (UAS, RFP) (100)